Reversal of Neuromuscular Blockade in Diabetic Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02057861|
Recruitment Status : Completed
First Posted : February 7, 2014
Last Update Posted : February 7, 2014
|Condition or disease|
|Observation of Neuromuscular Block|
Aim: In this study the investigators aimed to compare the time of antagonism and intensity of effect of sugammadex which is used for antagonism of rocuronium on diabetic and non-diabetic patients.
Methods: Included patients were divided into 2 groups: diabetic (n=21) and non-diabetic (n=20). All patients were premedicated. After arrival in the operating room, all patients were monitorised with Datex Ohmeda S/5 Anesthesia Machine and electrocardiography (DII derivation), hemodynamic variables, respiratory rate, and inspiratory sevoflurane concentrations were recorded. Neuromuscular monitoring system was used. Anesthesia was induced with propofol 2 mg/kg and fentanyl 1 mcg/kg. After the loss of eyelid reflex the neuromuscular monitoring system automatically identified supramaximal stimulating currents and after that rocuronium 0,6 mg/kg was given. Train of four (TOF) stimulation with the supramaximal current were applied and by recording of second TOF value (TOF2) the patient was intubated. Anesthesia was maintained with 50% O2 + 50% air and sevoflurane of 1-2 % concentration. TOF stimulation was applied and recorded every 20 seconds. Intraoperatively by return T2 rocuronium 0,15 mg/kg was given. T2i time was recorded as intubation time and T2d time was recorded as clinical effect time. At the end of the operation sugammadex 2 mg/kg was given. When TOF rate reached 0,9 patients were extubated and the time was recorded.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||45 participants|
|Target Follow-Up Duration:||9 Months|
|Official Title:||The Comparison of Reversal of Neuromuscular Blockade in Diabetic and Non-Diabetic Patients|
|Study Start Date :||January 2013|
|Actual Primary Completion Date :||August 2013|
|Actual Study Completion Date :||December 2013|
non-diabetic group; 2 mg/kg sugammadex iv, postoperatively Extubation times were recorded.
Diabetic group; 2 mg/kg sugammadex iv, postoperatively Extubation times were recorded
- reversal of diabetic patients [ Time Frame: 24 hours ]T2i time was recorded as intubation time and T2d time was recorded as clinical effect time. At the end of the operation sugammadex 2 mg/kg was given. When TOF rate reached 0,9 patients were extubated and the time was recorded.
- hemodynamic changes [ Time Frame: 24 hours ]Systolic, diastolic blood pressure and heart rate were recorded in the peroperative period
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02057861
|Duzce, Turkey, 81620|
|Principal Investigator:||yavuz demiraran, professor||Duzce University|